O

Orexigen Therapeutics

52 employees

Orexigen Therapeutics is a biopharmaceutical company focused on the treatment of obesity.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2002

Funding rounds raised

Total raised

$60M

from 13 investors over 13 rounds

O

Orexigen Therapeutics raised $60M on September 11, 2015

Investors: The Baupost Group

O

Orexigen Therapeutics raised $30M on November 22, 2006

Investors: WASATCH ADVISORS, INC and MPM Capital

O

Orexigen Therapeutics raised $35M on April 1, 2005

Investors: Montreux Equity Partners, Greenspring Associates, Kleiner Perkins, Morgenthaler, Domain Associates, Duke University and Scale Venture Partners

O

Orexigen Therapeutics raised $11M on January 22, 2004

Investors: Domain Associates, Sofinnova Ventures, Russia technology fund and Kleiner Perkins

FAQ